About UDP-glucose 6-dehydrogenase
UDP-glucose 6-dehydrogenase (UGDH) is a protein
from Homo sapiens identified by UniProt accession
O60701, 494 residues long.
MolForge cross-references it against 0 known binders and
98 disease associations.
Target properties
| Protein name | UDP-glucose 6-dehydrogenase |
| UniProt accession | O60701 |
| Gene | UGDH |
| Organism | Homo sapiens |
| Length | 494 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (98)
Diseases linked to this target (Open Targets).
- developmental and epileptic encephalopathy, 84 · score 0.76
- Epileptic encephalopathy · score 0.49
- neurodegenerative disease · score 0.34
- Herpes Zoster · score 0.29
- response to tofacitinib · score 0.29
- West syndrome · score 0.27
- neuroinflammatory disorder · score 0.25
- traffic air pollution measurement · score 0.23
- peripheral arterial disease · score 0.23
- glioblastoma multiforme · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O60701-F1 | alphafold | PREDICTED | 93.87 | — |
Amino-acid sequence (494 residues)
MFEIKKICCI GAGYVGGPTC SVIAHMCPEI RVTVVDVNES RINAWNSPTL PIYEPGLKEV VESCRGKNLF FSTNIDDAIK EADLVFISVN TPTKTYGMGK GRAADLKYIE ACARRIVQNS NGYKIVTEKS TVPVRAAESI RRIFDANTKP NLNLQVLSNP EFLAEGTAIK DLKNPDRVLI GGDETPEGQR AVQALCAVYE HWVPREKILT TNTWSSELSK LAANAFLAQR ISSINSISAL CEATGADVEE VATAIGMDQR IGNKFLKASV GFGGSCFQKD VLNLVYLCEA LNLPEVARYW QQVIDMNDYQ RRRFASRIID SLFNTVTDKK IAILGFAFKK DTGDTRESSS IYISKYLMDE GAHLHIYDPK VPREQIVVDL SHPGVSEDDQ VSRLVTISKD PYEACDGAHA VVICTEWDMF KELDYERIHK KMLKPAFIFD GRRVLDGLHN ELQTIGFQIE TIGKKVSSKR IPYAPSGEIP KFSLQDPPNK KPKV
Explore UDP-glucose 6-dehydrogenase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets